Jeffrey Rona
Chief Business and Financial Officer
Other
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Ovid Therapeutics Inc. (OVID) | Chief Business & Financial Officer | $506,892 | $969,164 |
| 2024 | Ovid Therapeutics Inc. (OVID) | Chief Business & Financial Officer | $492,128 | $1,518,796 |
| 2023 | Ovid Therapeutics Inc. (OVID) | Chief Business & Financial Officer | $469,257 | $1,061,098 |
| 2022 | Ovid Therapeutics Inc. (OVID) | Chief Business & Financial Officer | $473,200 | $1,609,368 |
| 2021 | Ovid Therapeutics Inc. (OVID) | Chief Business & Financial Officer | $455,000 | $973,317 |
| 2020 | Ovid Therapeutics Inc. (OVID) | Chief Business & Financial Officer | $107,860 | $1,989,076 |
Earnings-call appearances
No earnings-call appearances recorded yet.